Respiratory syncytial virus vaccine development

被引:48
作者
Crowe, JE
机构
[1] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA
关键词
respiratory syncytial virus (RSV); parainfluenza virus (PIV); vaccines;
D O I
10.1016/S0264-410X(01)00287-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Development of an RSV vaccine for infants has been hindered by the lack of an ideal animal model that exhibits disease, and the challenge of effectively immunizing very young infants who are immunologically immature. Nevertheless, significant progress has been made recently in developing live attenuated viruses and protein subunit vaccine candidates. Numerous vaccine candidates are currently in early clinical trials. This paper reviews the significant obstacles to development of RSV vaccines, and the progress made to date. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:S32 / S37
页数:6
相关论文
共 56 条
[1]   A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is at attenuated in primates [J].
Bailly, JE ;
McAuliffe, JM ;
Durbin, AP ;
Elkins, WR ;
Collins, PL ;
Murphy, BR .
JOURNAL OF VIROLOGY, 2000, 74 (07) :3188-3195
[2]   Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): Effects on host range and evaluation as a live-attenuated HRSV vaccine [J].
Buchholz, UJ ;
Granzow, H ;
Schuldt, K ;
Whitehead, SS ;
Murphy, BR ;
Collins, PL .
JOURNAL OF VIROLOGY, 2000, 74 (03) :1187-1199
[3]   Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines [J].
Bukreyev, A ;
Whitehead, SS ;
Prussin, C ;
Murphy, BR ;
Collins, PL .
JOURNAL OF VIROLOGY, 2000, 74 (15) :7151-7157
[4]   CYTO-TOXIC T-CELLS CLEAR VIRUS BUT AUGMENT LUNG PATHOLOGY IN MICE INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS [J].
CANNON, MJ ;
OPENSHAW, PJM ;
ASKONAS, BA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) :1163-1168
[5]   A peptide mimic of a protective epitope of respiratory syncytial virus selected from a combinatorial library induces virus-neutralizing antibodies and reduces viral load in vivo [J].
Chargelegue, D ;
Obeid, OE ;
Hsu, SC ;
Shaw, MD ;
Denbury, AN ;
Taylor, G ;
Steward, MW .
JOURNAL OF VIROLOGY, 1998, 72 (03) :2040-2046
[6]   PRODUCTION OF INFECTIOUS HUMAN RESPIRATORY SYNCYTIAL VIRUS FROM CLONED CDNA CONFIRMS AN ESSENTIAL ROLE FOR THE TRANSCRIPTION ELONGATION-FACTOR FROM THE 5'-PROXIMAL OPEN READING FRAME OF THE M2 MESSENGER-RNA IN GENE-EXPRESSION AND PROVIDES A CAPABILITY FOR VACCINE DEVELOPMENT [J].
COLLINS, PL ;
HILL, MG ;
CAMARGO, E ;
GROSFELD, H ;
CHANOCK, RM ;
MURPHY, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) :11563-11567
[7]   COTTON RATS PREVIOUSLY IMMUNIZED WITH A CHIMERIC RSV FG GLYCOPROTEIN DEVELOP ENHANCED PULMONARY PATHOLOGY WHEN INFECTED WITH RSV, A PHENOMENON NOT ENCOUNTERED FOLLOWING IMMUNIZATION WITH VACCINIA RSV RECOMBINANTS OR RSV [J].
CONNORS, M ;
COLLINS, PL ;
FIRESTONE, CY ;
SOTNIKOV, AV ;
WAITZE, A ;
DAVIS, AR ;
HUNG, PP ;
CHANOCK, RM ;
MURPHY, BR .
VACCINE, 1992, 10 (07) :475-484
[8]   RESPIRATORY SYNCYTIAL VIRUS (RSV) F-PROTEIN, G-PROTEIN, M2-PROTEIN (22K), AND N-PROTEINS EACH INDUCE RESISTANCE TO RSV CHALLENGE, BUT RESISTANCE INDUCED BY M2-PROTEINS AND N-PROTEINS IS RELATIVELY SHORT-LIVED [J].
CONNORS, M ;
COLLINS, PL ;
FIRESTONE, CY ;
MURPHY, BR .
JOURNAL OF VIROLOGY, 1991, 65 (03) :1634-1637
[9]   COLD PASSAGED, TEMPERATURE-SENSITIVE MUTANTS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) ARE HIGHLY ATTENUATED, IMMUNOGENIC, AND PROTECTIVE IN SERONEGATIVE CHIMPANZEES, EVEN WHEN RSV ANTIBODIES ARE INFUSED SHORTLY BEFORE IMMUNIZATION [J].
CROWE, JE ;
BUI, PT ;
SIBER, GR ;
ELKINS, WR ;
CHANOCK, RM ;
MURPHY, BR .
VACCINE, 1995, 13 (09) :847-855
[10]   A COMPARISON IN CHIMPANZEES OF THE IMMUNOGENICITY AND EFFICACY OF LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) TEMPERATURE-SENSITIVE MUTANT VACCINES AND VACCINIA VIRUS RECOMBINANTS THAT EXPRESS THE SURFACE GLYCOPROTEINS OF RSV [J].
CROWE, JE ;
COLLINS, PL ;
LONDON, WT ;
CHANOCK, RM ;
MURPHY, BR .
VACCINE, 1993, 11 (14) :1395-1404